Search:
All Dates (UTC+8):
  • All
  • 2025-06-06 [Friday]
  • 2025-06-07 [Saturday]
  • 2025-06-08 [Sunday]
All Rooms:
  • All
  • Watson Auditorium
  • Exhibition Area II
  • Exhibition Area III
  • Meeting Room M1
  • Meeting Room F1
  • Meeting Room M2
  • Meeting Room M6
  • Meeting Room M4

2025-06-06 Friday

Exhibition Area II (UTC+8)

14:00-15:00 (UTC+8) | Executive Master of Interventional Radiology (EMIR) - I
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:00-14:07

Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE after Biliary Drainage: TEMP Score

Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China
2 14:07-14:14

Thermosensitive Nanogel: A Novel Embolic Agent of TACE for HCC

Rong Ding Yunnan Provincial Cancer Hospital, China
3 14:14-14:21

Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced HCC Patients Receiving TACE plus Systemic Therapies

Jin-Feng Bai Yunnan Provincial Cancer Hospital, China
4 14:21-14:28

TACE Combined with Systemic Therapy for Unresectable Liver Cancer

Ning Ai The Fourth Hospital of Hebei Medical University, China
5 14:28-14:35

TACE and TKIs with or without PD-1 as First-line Treatment for Unresectable HCC: A Propensity Score Matching Study

Xue-Gang Yang Sichuan Cancer Hospital & Institute, China
6 14:35-14:42

MWA vs. RFA Combined with Vertebroplasty for Vertebral Metastatic Tumors: A Retrospective Cohort Study

Fu-An Wang Jiangsu Subei People's Hospital, China
7 14:42-15:00

Panelists

Hai-Dong Zhu Zhongda Hospital, Southeast University, China / Alex Tang Subang Jaya Medical Centre,Malaysia / Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China / Rong Ding Yunnan Provincial Cancer Hospital, China / Jin-Feng Bai Yunnan Provincial Cancer Hospital, China / Ning Ai The Fourth Hospital of Hebei Medical University, China / Xue-Gang Yang Sichuan Cancer Hospital & Institute, China / Fu-An Wang Jiangsu Subei People's Hospital, China / Jian-Bo Zhao Southern Hospital of Southern Medical University, China
15:00-16:00 (UTC+8) | Executive Master of Interventional Radiology (EMIR) - II
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 15:00-15:07

Fruquintinib Combined with Sintilimab plus TACE for Unresectable HCC: A Single-arm Phase 2 Study

Hui Zeng Zhejiang Provincial Cancer Hospital, China
2 15:07-15:14

Predictive Model of Unresectable HCC Treated with TACE-HAIC Combined with TKIs and ICIs

Li-Nan Yin Harbin Medical Univisity Cancer Hospital, China
3 15:14-15:21

Transformation of IR Workflow through Smart Operating Room Development: Technological Integration and Clinical Practice

Lin Zhu Zhongshan Hospital Affiliated with Fudan University, China
4 15:21-15:28

Can Commonly Used Large Language Models Be Recommend Interventional Therapy to Liver Cancer Patients?

Zhi-Hui Chang Shengjing Hospital of China Medical University, China
5 15:28-15:35

Association between TACE Refractoriness and Prognosis in Chinese Patients with HCC: A Retrospective Cohort Study

Qin-Xue Sun Ningbo Medical Center Li Huili Hospital, China
6 15:35-16:00

Panelists

Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea / Prijo Sidipratomo Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia / Hui Zeng Zhejiang Provincial Cancer Hospital, China / Li-Nan Yin Harbin Medical Univisity Cancer Hospital, China / Lin Zhu Zhongshan Hospital Affiliated with Fudan University, China / Zhi-Hui Chang Shengjing Hospital of China Medical University, China / Qin-Xue Sun Ningbo Medical Center Li Huili Hospital, China
16:00-18:00 (UTC+8) | Passing the Torch Mentoring Program
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:10

Passing the Torch Mentoring Program: Introduction

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
2 16:10-16:20

Passing the Torch Mentoring Program: Leading Mission I

Hang Yuan Henan Cancer Hospital, China
3 16:20-16:30

Passing the Torch Mentoring Program: Leading Mission II

Bing-Jie Zheng Henan Cancer Hospital, China
4 16:30-16:40

Passing the Torch Mentoring Program: Leading Mission IIIa

Hang Yuan Henan Cancer Hospital, China
5 16:40-16:50

Passing the Torch Mentoring Program: Leading Mission IIIb

Shi-Jun Xu Henan Cancer Hospital, China
6 16:50-17:00

Passing the Torch Mentoring Program: Leading Mission IV

Hong-Tao Hu Henan Cancer Hospital, China
7 17:00-17:10

Passing the Torch Mentoring Program: Leading Mission V

Xi Li The Fifth Affiliated Hospital of Sun Yat-sen University, China
8 17:10-17:20

Passing the Torch Mentoring Program: Leading Mission VI

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
9 17:20-18:00

Q & A and Panel Discussion (Overcoming Miscommunication & Shaping the Future)

Jiaywei Tsauo Guangdong Provincial People's Hospital, China / Bin-Yan Zhong Zhejiang Cancer Hospital, China